Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 135 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1341 9.0 months Recurrent GBM 4 Chemotherapy
Bellaria Hospital Italy 8/2004
Treatment Details: Patients: This Phase II study involved 25 patients with recurrent glioblastoma multiforme and 5 patients with recurrent anaplastic astrocytoma. All patients had been previously treated with
 
1342 9.0 months Metastatic colorectal cancer 4 Chemotherapy
Surgery
The University of Texas, MD Anderson Cancer Center United States 1/2004
Treatment Details: Patients: This Phase II study involved 15 evaluable patients with metastatic colorectal cancer (adenocarcinoma). Treatment: The treatment consisted of the chemotherapy drug exatecan mes
 
1343 9.0 months Advanced NSCLC 4 Chemotherapy
University of Palermo Italy 2/2003
Treatment Details: Patients: This Phase III study involved 278 patients with advanced (stage IIIB-IV) non-small cell cancer. (The study started with 400 patients, but two accrual groups were terminated early.
 
1344 9.0 months Malignant Pleural Mesothelioma 2 Immunotherapy
St. Bartholomew's Hospital United Kingdom 1/2001
Treatment Details: Patients: This Phase II study involved 29 patients with malignant pleural mesothelioma. None of these patients had been administered previous chemotherapy or immunotherapy. Treatment: Th
 
1345 9.0 months Metastatic colorectal cancer 4 Chemotherapy
Surgery
The University of Texas, MD Anderson Cancer Center United States 1/2004
Treatment Details: Patients: This Phase II study involved 15 evaluable patients with metastatic colorectal cancer (adenocarcinoma). Treatment: The treatment consisted of the chemotherapy drug exatecan mes
 
1346 9.0 months metastatic melanoma 4 Chemotherapy
Immunotherapy
Campus Benjamin Franklin Germany 9/2005
Treatment Details: Patients: This Phase III study involved a total of 363 patients with metastatic melanoma who were divided into two groups: Group A of 180 patients and Group B of 183 patients. For Group A t
 
1347 9.0 months metastatic melanoma 4 Chemotherapy
Immunotherapy
Campus Benjamin Franklin Germany 9/2005
Treatment Details: Patients: This Phase III study involved a total of 363 patients with metastatic melanoma who were divided into two groups: Group A of 180 patients and Group B of 183 patients. For Group B t
 
1348 9.0 months Advanced rcc 4 Biologic therapy
University of Kansas Medical Center United States 7/2005
Treatment Details: Patients: This Phase II study involved 38 patients with advanced renal cell carcinoma. Thirty-four patients were considered eligible - 22 men and 12 women. Twenty-four patients had prior n
 
1349 9.0 months Metastatic urothelial carcinoma 4 Chemotherapy
National Cancer Center Korea 5/2011
Treatment Details: Patients: This study involved 21 metastatic urothelial carcinoma patients who had received two prior platinum-based chemotherapy regimens. The median patient age was 64 years and 61.9% wer
 
1350 9.0 months Diffuse large B-cell lymphoma 4 Biologic therapy
Stanford University United States 7/2013
Treatment Details: Patients: This phase 2 study involved 14 recurrent diffuse large B cell lymphoma patients who had been previously treated. The median patient age was 69.5 years and 9 were male. Treatme
 
Page 135 of 187  | Previous Page  | Next Page